Trial Profile
An Open Pilot Study of Varenicline (Chantix) in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD): Effects on ADHD and Cigarette Smoking.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2017
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Attention-deficit hyperactivity disorder; Smoking withdrawal
- Focus Therapeutic Use
- 11 May 2010 Actual patient number (2) added as reported by ClinicalTrials.gov.
- 11 May 2010 Planned end date changed from 1 Apr 2012 to 1 May 2010 as reported by ClinicalTrials.gov.
- 11 May 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.